Cystic fibrosis (CF) affects more than 30,000 people in the United States and 80,000 people
worldwide. This life-threatening genetic disorder causes a buildup of thick, viscous mucus …

Cystic fibrosis (CF) affects 70,000 patients worldwide. Morbidity and mortality in CF is largely
caused by lung complications due to the triad of impaired mucociliary clearance, microbial …

Cystic fibrosis (CF) is an autosomal recessive genetic disorder characterized by dysfunction
of the CFTR gene. It is a multisystem disease that most often affects White individuals. In …

RESUMO A fibrose cística (FC) é uma doença genética autossômica recessiva
caracterizada pela disfunção do gene CFTR. Trata-se de uma doença multissistêmica que …

Etiological therapies aim at repairing the underlying cause of cystic fibrosis (CF), which is
the functional defect of the cystic fibrosis transmembrane conductance regulator (CFTR) …

This study aims to investigate the solid lipid nanoparticle (SLN) as a novel vehicle for the
sustained release and transdermal delivery of piroxicam, as well as to determine the anti …

Bleomycin (BLM) has potent tumor cell-killing properties that have given it an important
place in cancer chemotherapy, but pulmonary toxicity is its major adverse effect. Soluble …

Background: A potential larger perceived placebo effect in children compared with adults
could influence the detection of the treatment effect and the extrapolation of the treatment …

Rationale: Cystic fibrosis (CF) lung disease progresses by a combination of airway
inflammation, bacterial colonization, and infection. Airway inflammation is predominantly …

Lung Epithelial Biology in the Pathogenesis of Pulmonary Disease provides a one-stop
resource capturing developments in lung epithelial biology related to basic physiology …